Comparison of prophylactic effect single-dose Celecoxib and Mefenamic acid
- Conditions
- Tooth extraction.
- Registration Number
- IRCT20220407054442N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Patients over 14 years and of any sex who do not have a serious systemic disease and are classified in class 1 or 2 of The American Society of Anesthesiologists (ASA) will be included in this study.
Patients who referred for tooth extraction due to periodontal support problem will not be included in the study.
Patients with symptoms of infection such as swelling, fever, pus discharge, and decreased mouth opening will also not be included in the study.
Patients who need analgesics for any reason other than toothache will not be included in the study.
Patients who have a history of taking any painkillers up to 12 hours before tooth extraction will not be included in this study.
Patients with systemic physical or mental illness or at risk for infectious endocarditis, coagulation problems, local and systemic infections, known allergies to celecoxib or mefenamic acid, a history of asthma, or drug or alcohol addiction will not be included in this study.
Patients who require severe surgical intervention to extract a tooth will not be included in this study.
celecoxib is contraindicated in patients with heart problems. Therefore, patients with heart disease will not participate in this study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method